Aerin Medical

Aerin Medical is a Sunnyvale, California-based medical device company that develops non-invasive, temperature-controlled radiofrequency technologies to treat chronic nasal conditions. The enterprise provides specialized ear, nose, and throat physicians with FDA-cleared systems, specifically the VivAer and RhinAer devices, to address nasal airway obstruction and chronic rhinitis without traditional surgery. Operating with an estimated 100 to 250 employees, the business generates revenue through the direct sale of its proprietary single-use consoles to clinics and hospitals. The organization has treated over 100,000 patients globally and secured more than $100 million in total equity financing, including a $60 million round in 2022. This financial backing has been driven by institutional investors such as Ally Bridge Group, OrbiMed, Questa Capital, and KCK Group. Aerin Medical was originally founded in 2011 by Dr. Scott Wolf, Andrew Frazier, and Andrew Lux.